JW Pharmaceutical Corporation (001060.KS) KSC

25,950.00

-400(-1.52%)

Updated at December 05 02:35PM

Currency In KRW

Valuation

Market Cap559.8B
Enterprise Value641.1B
P/E Ratio11.63
PEG Ratio-0.69
Price/Sales Ratio0.81
Price/Book Ratio1.87
Enterprise/Revenue0.92
Enterprise/EBITDA3.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.12

Management Effectiveness

Return On Assets0.09
Return On Equity0.16

Income Statement

Revenue719.38B
Revenue/Share32,012.37
Gross Profit323.5B
EBITDA110.17B
Net Income65.04B
Diluted EPS2,644.47

Balance Sheet

Total Cash72.53B
Total Cash/Share1,508.94
Total Debt90.73B
Total Debt/Equity0.28
Current Ratio1.41
Book Value Per Share13,931.31

Price History

52-Week Change10.64
52-Week High26,650
52-Week Low19,600
Moving Average 50 Days23,419
Moving Average 200 Days22,553.45

Statistics

Average Volume67,765
Shares Outstanding23.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield1.73
Payout Ratio0.21
Last Split Factor51:50
Last Split DateDecember 27, 2023